Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

RPS6KA3 Antikörper

RPS6KA3 Reaktivität: Human WB, ELISA, FACS, ICC Wirt: Maus Monoclonal 4-00E-10 unconjugated
Produktnummer ABIN969386
  • Target Alle RPS6KA3 Antikörper anzeigen
    RPS6KA3 (Ribosomal Protein S6 Kinase, 90kDa, Polypeptide 3 (RPS6KA3))
    Reaktivität
    • 181
    • 125
    • 65
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    Human
    Wirt
    • 181
    • 16
    • 1
    Maus
    Klonalität
    • 183
    • 15
    Monoklonal
    Konjugat
    • 66
    • 13
    • 9
    • 8
    • 7
    • 7
    • 7
    • 7
    • 7
    • 7
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 3
    • 2
    Dieser RPS6KA3 Antikörper ist unkonjugiert
    Applikation
    • 90
    • 68
    • 67
    • 53
    • 28
    • 24
    • 17
    • 15
    • 12
    • 6
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    Western Blotting (WB), ELISA, Flow Cytometry (FACS), Immunocytochemistry (ICC)
    Aufreinigung
    purified
    Immunogen
    Purified recombinant fragment of human RSK2 expressed in E. coli.
    Klon
    4-00E-10
    Isotyp
    IgG1
  • Applikationshinweise
    ELISA: 1:10000, WB: 1:500 - 1:2000, ICC: 1:200 - 1:1000, FCM: 1:200 - 1:400
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer
    Ascitic fluid containing 0.03 % sodium azide.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C/-20 °C
    Informationen zur Lagerung
    4°C, -20°C for long term storage
  • Dehan, Bassermann, Guardavaccaro, Vasiliver-Shamis, Cohen, Lowes, Dustin, Huang, Taunton, Pagano: "betaTrCP- and Rsk1/2-mediated degradation of BimEL inhibits apoptosis." in: Molecular cell, Vol. 33, Issue 1, pp. 109-16, (2009) (PubMed).

    Cho, Yao, Pugliese, Malakhova, Bode, Dong: "A regulatory mechanism for RSK2 NH(2)-terminal kinase activity." in: Cancer research, Vol. 69, Issue 10, pp. 4398-406, (2009) (PubMed).

  • Target
    RPS6KA3 (Ribosomal Protein S6 Kinase, 90kDa, Polypeptide 3 (RPS6KA3))
    Andere Bezeichnung
    RSK2 (RPS6KA3 Produkte)
    Synonyme
    HU-1 antikoerper, MAPKAPK1A antikoerper, RSK antikoerper, RSK1 antikoerper, CLS antikoerper, HU-3 antikoerper, ISPK-1 antikoerper, MAPKAPK1B antikoerper, MRX19 antikoerper, RSK2 antikoerper, S6K-alpha3 antikoerper, p90-RSK2 antikoerper, pp90RSK2 antikoerper, MPK-9 antikoerper, Rsk2 antikoerper, RGD1563860 antikoerper, id:ibd1103 antikoerper, rps6ka3 antikoerper, si:ch211-114c12.12 antikoerper, wu:fk86e02 antikoerper, zgc:56006 antikoerper, zgc:158386 antikoerper, ribosomal protein S6 kinase A1 antikoerper, ribosomal protein S6 kinase A3 antikoerper, ribosomal protein S6 kinase polypeptide 3 antikoerper, ribosomal protein S6 kinase a, polypeptide 3a antikoerper, ribosomal protein S6 kinase, polypeptide 3b antikoerper, RPS6KA1 antikoerper, RPS6KA3 antikoerper, Rps6ka3 antikoerper, rps6ka3a antikoerper, rps6ka3b antikoerper
    Hintergrund

    Description: This gene encodes a member of the RSK (ribosomal S6 kinase) family of serine/threonine kinases. This kinase contains 2 non-identical kinase catalytic domains and phosphorylates various substrates, including members of the mitogen-activated kinase (MAPK) signalling pathway. The activity of this protein has been implicated in controlling cell growth and differentiation. Mutations in this gene have been associated with Coffin-Lowry syndrome (CLS).

    Aliases: RPS6KA3, CLS, RSK, HU-3, RSK2, MRX19, ISPK-1, p90-RSK2, pp90RSK2, MAPKAPK1B, S6K-alpha3

    Molekulargewicht
    80 kDa
    Gen-ID
    6197
    HGNC
    6197
    Pathways
    MAPK Signalweg, Neurotrophin Signalübertragung, Activation of Innate immune Response, Toll-Like Receptors Cascades
Kundenservice